Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: Impact of adjuvant treatment (Hormonal and radiation)

Journal of Urology

Volumn 145, Issue 2, 1991, Pages 319-323

  Morgan, W R ^a   Zincke, H ^a   Rainwater, L M ^a   Myers, R P ^a   Klee, G G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adenocarcinoma; Antigens, differentiation; Hormone; Prostate; Radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER STAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATECTOMY; RADIOTHERAPY;

EID: 0025976684     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(17)38327-1     Document Type: Article

References (21)

1. Wang M.C. Valenzuela L.A. Murphy G.P. Chu T.M. Purification of a human prostate specific antigen Invest. Urol. 17 1979 159
2. Nadji M. Tabei S.Z. Castro A. Chu T.M. Murphy G.P. Wang M.C. Morales A.R. Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms Cancer 48 1981 1229
3. Wang M.C. Papsidero L.D. Kuriyama M. Valenzuela L.A. Murphy G.P. Chu T.M. Prostate antigen: a new potential marker for prostatic cancer Prostate 2 1981 89
4. Oesterling J.E. Chan D.W. Epstein J.I. Kimball A.W. Jr. Bruzek D.J. Rock R.C. Brendler C.B. Walsh P.C. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy J. Urol. 139 1988 766
5. Zincke H. Fleming T.R. Furlow W.L. Myers R.P. Utz D.C. Radical retropubic prostatectomy and pelvic lymphade-nectomy for high-stage cancer of the prostate Cancer 47 1981 1901
6. Ercole C.J. Lange P.H. Mathisen M. Chiou R.K. Reddy P.K. Vessella R.L. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer J. Urol. 138 1987 1181
7. Stamey T.A. Yang N. Hay A.R. McNeal J.E. Freiha F.S. Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate New Engl. J. Med. 317 1987 909
8. Stamey T.A. Kabalin J.N. McNeal J.E. Johnstone I.M. Freiha F. Redwine E.A. Yang N. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients J. Urol. 141 1989 1076
9. Hortin G.L. Bahnson R.R. Daft M. Chan K.-M. Catalona W.J. Ladenson J.H. Differences in values obtained with 2 assays of prostate specific antigen J. Urol. 139 1988 762
10. Moul J.W. Miles B.J. Skoog S.J. McLeod D.G. Risk factors for perineal seeding of prostate cancer after needle biopsy J. Urol. 142 1989 86
11. Benson R.C. Jr. Tomera K.M. Zincke H. Fleming T.R. Utz D.C. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for adenocarcinoma confined to the prostate J. Urol. 131 1984 1103
12. Zincke H. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for stage C or D1 adenocarcinoma of the prostate: possible beneficial effect of adjuvant treatment Natl. Cancer Inst. Monogr. 7 1988 109
13. Lange P.H. Reddy P.K. Medini E. Levitt S. Fraley E.E. Radiation therapy as adjuvant treatment after radical prostatectomy Natl. Cancer Inst. Monogr. 7 1988 141
14. Lightner D.J. Reddy P.K. Lange P.H. PSA response to radiation therapy (RT) after radical prostatectomy (RP): correlation with biopsy (BX) and rectal exam J. Urol. 141 1989 183A part 2, abstract 55
15. Csapo Z. Brand K. Walther R. Fokas K. Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice J. Urol. 140 1988 1032
16. Bruchovsky N. Brown E.M. Coppin C.M. Goldenberg S.L. Le Riche J.C. Murray N.C. Rennie P.S. The endocrinology and treatment of prostate tumor progression Prog. Clin. Biol. Res. 239 1987 347
17. Isaacs J.T. The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer Prostate 5 1984 1
18. Partin A.W. Carter H.B. Chan D.W. Epstein J.I. Oesterling J.E. Rock R.C. Weber J.P. Walsh P.C. Prostate-specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia J. Urol. 143 1990 747
19. Keillor J.S. Aterman K. The response of poorly differentiated prostatic tumors to staining for prostate specific antigen and prostatic acid phosphatase: a comparative study J. Urol. 137 1987 894
20. Goldfarb D.A. Stein B.S. Shamszadeh M. Petersen R.O. Age-related changes in tissue levels of prostatic acid phosphatase and prostate specific antigen J. Urol. 136 1986 1266
21. Morgan W.R. Zincke H. Bergstralh E. Residual cancer (RC) after bilateral pelvic lymphadenectomy (PLA) and radical retropubic prostatectomy (RP) for stage C prostate cancer (PC): impact on local and systemic progression and cause specific survival J. Urol. 141 1989 505A part 2, abstract 505A